Comprehensive Analysis of DNA Methylation and Transcriptome to Identify PD-1-Negative Prognostic Methylated Signature in Endometrial Carcinoma

<div>Determination and functional analysis of differentially expressed genes. (a) The difference of PD-1 expression between EC and normal tissues. (b) Volcanic map of DEGs between tumor tissue and normal tissue. (c) The difference of stromal score and immune score and ESTIMA TE score between tumor tissue and normal tissue. (d) Unsupervised hierarchical clustering heat map of differential genes. (e) Top 10 GO analysis of 4153 DEGs from the aspects of BP, CC and MF. (f) Top 10 KEGG analysis of 4153 DEGs.</div>

Disease Markers

fig1

Figure 1

Figure 1: Comprehensive Analysis of DNA Methylation and Transcriptome to Identify PD-1-Negative Prognostic Methylated Signature in Endometrial Carcinoma 

Figure 1 | Comprehensive Analysis of DNA Methylation and Transcriptome to Identify PD-1-Negative Prognostic Methylated Signature in Endometrial Carcinoma 